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Background: The purpose of this study was to examine changes in the airway lumen and 
parenchyma in relation to lung function in patients with chronic obstructive pulmonary disease 
(COPD) compared with controls.
Methods: We studied 70 patients with COPD and 15 normal subjects. Using reconstructed 
computed tomography (CT) images, we traced the bronchial trees and reconstructed 3 cm circle 
images around the airways exactly perpendicular to the airway axis at the peripheral, middle, 
and central zones of the bronchi. We measured the number of airways and vessels, the airway 
inner diameter, and the area of emphysema in the circles, and analyzed the relationship of these 
image parameters to lung function.
Results: Reduced airway numbers and increased upper lobe emphysema were observed even in 
early spirometric stages in patients with COPD compared with controls. Other findings included 
decreased airway inner diameter in advanced spirometric stages. The numbers of peripheral 
zone bronchi, the extent of the middle zone emphysematous area, and the mean airway inner 
diameter of the airways were the best predictors of spirometric parameters. A portion of the 
airways in patients with COPD showed a loss of airway patency at middle or central zone 
bronchi predominantly in the late spirometric stages. Lumen-obliterated bronchial trees could 
be traced into emphysematous areas showing air trapping.
Conclusion: Compared with controls, our CT observations in patients with COPD showed 
that airway lumen and lung parenchyma changes along airways differed by spirometric stage, 
and these changes were associated with decreased lung function. A portion of CT-identified 
emphysema in patients with COPD appeared to be due to lumen-obliterated airways in the 
bronchial tree.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by reduced airflow at 
forced expiration.1 This airflow reduction may be caused by the loss of alveolar attach-
ment to airways and the narrowing of the small airways, defined as 2 mm in diameter 
and characteristic of COPD.2–6 However, the reduced airflow in COPD may not be fully 
explained by structural changes in the small airways. The differences in the cross-
sectional area between the central and peripheral airways cause airflow through the 
central airways to be rapid compared with that through the peripheral airways. Collapse 
of the central airways at expiration occurs easily in patients with COPD.7 Therefore, 
the large airways might be also involved in the flow limitation associated with COPD. 
Recently, other structural changes, notably in the small airways, have been postulated as International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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contributing to COPD pathology. McDonough et al8 showed 
that the number of small airways was significantly reduced 
in patients with COPD. Computed tomography (CT) allows 
study of both emphysema and the small airways in COPD, 
and we sought to amplify on the studies of McDonough et al 
by looking at in vivo CT scan data in association with Global 
initiative for chronic Obstructive Lung Disease (GOLD) 
stages,1 which is different from the in vitro lung slice CT 
scan data used by McDonough et al.
Based on recent pathologic concepts of COPD, we 
hypothesized that lung structures at different levels along 
the airways at rest (ie, airway numbers, airway diameter, and 
emphysema around airways) might correlate differently with 
reduced airflow at forced expiration.
In this study, we first evaluated airways from the level of 
the segmental bronchi to peripheral airways that were less 
than 1 mm in diameter by reconstructing the airway longitu-
dinal structure with ultrahigh resolution (UHR) CT and noise 
reduction software (iDose4; Philips Healthcare, Cleveland, 
OH, USA). We then reconstructed a 3 cm circle around 
the airway perpendicular to the long axis at the peripheral, 
middle, and central zones of the airway in the right B1–B10 
bronchial trees. We subsequently studied whether airway 
inner diameter (Di), low attenuation area, and numbers of 
airways and vessels in the circles at the three levels of bronchi 
were associated with different severity of airflow limitation in 
patients with COPD, and examined the relationship between 
these lung structures and spirometric parameters.
Materials and methods
Patients
The study was prospective, and consecutive patients with 
COPD who visited Saitama Cardiovascular and Respira-
tory Center (a tertiary referral hospital for respiratory dis-
ease with 315 beds) were recruited from March 1, 2012 to 
October 31, 2012. The institutional review board of Saitama 
  Cardiovascular and Respiratory Center approved this study 
(2011002), and only patients who gave their written informed 
consent were included.
Since female patients with COPD make up less than 5% 
of the patients in our clinic, we studied male patients with 
COPD who underwent high-resolution CT for evaluation of 
emphysema. All patients were clinically stable at the time 
of the study. Exclusion criteria were a history of allergy, 
episodic wheeze, and high serum immunoglobulin E. The 
control group consisted of normal male patients who under-
went chest high-resolution CT for minor chest abnormalities 
noted on chest radiographs.
Pulmonary function tests
Pulmonary  function  tests  were  performed  with  a 
CHESTAC-8800 (Chest MI Inc, Tokyo, Japan). Pulmo-
nary function test data included measurements of forced 
vital   capacity (FVC), forced expiratory volume in one 
second (FEV1), and maximum expiratory flow at 75% FVC 
(MEF75), 50% FVC (MEF50), and 25% FVC (MEF25). 
Methods and predicted values for spirometric measurements 
were derived from the guidelines for pulmonary function 
tests issued by the American Thoracic Society/European 
Respiratory Society and Japanese Respiratory Society.9,10 
Spirometry was performed before and 30 minutes after 
inhalation of 200 µg of salbutamol, and the data obtained 
after inhalation of salbutamol were used for evaluation. 
Since CT scanning and pulmonary function tests were 
done in stable patients, the pulmonary function test results 
obtained within one month of the CT study were considered 
acceptable for the analysis.
CT data acquisition and reconstruction
A multislice (256 slices) CT scanner (Brilliance iCT; Philips 
Healthcare) was used. CT scans were acquired with the 
following parameters: a tube voltage of 120 kilovolts peak 
(kVp); a tube current-time product of 200 milliamperes per 
second (mAs); a detector configuration of 20 × 0.625 mm col-
limation with UHR mode; a reconstruction section thickness 
of 0.67 mm; helical mode with 0.55 pitch; gantry rotation 
time 0.4 seconds; and display field of view 200 mm. The 
radiation dose in our study protocol was about 11.2 mSv 
(conventional posterior-anterior and lateral chest X-ray is 
about 0.1 or 0.2 mSv).
UHR mode introduces a collimator in front of the detec-
tors so that after the beam emerges from the patient, it is 
collimated before hitting the detectors. Collimators increase 
spatial resolution, but at the expense of lower dose efficiency 
because they absorb half of the photon flux before reach-
ing the detectors. As a result, and because of the high-pass 
reconstruction kernel design, image noise was increased. 
All images were reconstructed from UHR data using an 
iterative reconstruction algorithm (iDose4 ).11–13 The iDose4 
offers six levels of image noise reduction in the UHR mode. 
We selected the highest level (level 6) to obtain maximum 
noise reduction of almost 50%. Patients were asked to 
continue deep inspiration for a while and all scans were 
obtained immediately afterward. Reconstructed data were 
transferred to the workstation (Philips Healthcare), and 
then superimposed on a curved multiplanar reconstruction 
of the airways.International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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analysis of airway structure
We measured lung structures in one airway for each of the 
ten segments in the right upper lobe (ie, B1b, B2b, and B3b), 
right middle lobe (ie, B4b and B5b), and right lower lobe 
(B6b, B7b, B8b, B9a, and B10b). Each bronchial tree was 
traced from the most peripheral point of the airway (within 
2 cm of the pleura) to the entrance of the segmental bronchus. 
We designated the point in the airway 2 cm from the pleura 
as the peripheral zone, the point 2 cm from the entrance of 
the segmental bronchus as the central zone, and the point 
halfway between those two points as the middle zone. At each 
point, we reconstructed perpendicular images to the axis of 
the airway and placed a 3 cm circle with the selected airway in 
the center. In a preliminary study, we determined that the 3 cm 
circle was the largest circle that could be used to avoid over-
lapping circles in the central zone and to avoid chest wall, 
diaphragm, or pleura in the middle and peripheral zones. For 
this reason, we could select only one airway in each segment 
to examine in detail. Using a method previously reported, 
with minor modifications, the percentage of low attenuation 
area (%LAA) was calculated in the circle.14–16 The cutoff 
level between normal lung density and LAA was defined as 
–960 Hounsfield units. The numbers of airways, the numbers 
of arteries and veins, and the Di of the airway in the center 
of the circle were measured. Di of an obliterated airway was 
calculated as zero. Nodular structures and linear structures 
other than membranous structures (presumably interlobular 
septa) were considered vessels (ie, artery or veins). The 
peripheral point on the airway in each segment was determined 
by the consensus of two observers (KK, TH, TK, or MU). We 
independently reviewed all the CT data, such as counting of 
number of airways and vessels on the same acquired images. 
The mean values were calculated and used for this study.
Phantom study
We performed validation analysis by using two phantoms 
(A and B) to test the software, as previously described.17 
Phantom A had a Di of 0.8 mm and a wall thickness of 
0.7 mm. Phantom B had a Di of 1.0 mm and a wall thick-
ness of 0.6 mm.
statistical analysis
Demographic data were expressed as the mean (standard 
deviation), and values for each parameter are expressed as 
the mean (standard error). Analysis of variance with the 
Tukey–Kramer multiple comparison test was used to com-
pare groups. Nonparametric comparison by segments was 
performed using the Kruskal–Wallis test. Linear regression 
analysis and stepwise multiple regression analysis were 
used to evaluate the relationship between CT parameters 
and outcomes of the pulmonary function tests. An intraclass 
correlation coefficient over 0.6 was considered acceptable for 
variability between observers and repeated measurements. 
Statistical significance was set at P,0.05.
Results
CT measurements and reconstructed 
lung airway images
Phantom study
Images of the two phantoms (A and B) and a reference phantom 
(Di of 0.3 mm) by high-resolution CT and by UHR CT with and 
without iDose4 software are shown in Figure 1. Measurements 
were repeated three times for each phantom. The intraclass cor-
relation coefficients were 0.76 and 0.62, respectively, for phantom 
A and phantom B. The results of the Di (0.8 mm) and wall thick-
ness (0.7 mm) measurements of phantom A were 0.85±0.05 mm 
(mean coefficient of variation, 5.96%) and 0.71±0.03 mm (mean 
coefficient of variation, 4.06%). The results of Di (1 mm) and 
wall thickness (0.6 mm) for phantom B were 0.91±0.03 mm 
(mean coefficient of variation, 3.17%) and 0.59±0.04 mm (mean 
coefficient of variation, 6.06%), respectively. These data indicate 
that measurement of airway dimensions by the software is very 
accurate and reproducible for airways with a Di $0.8 mm.
reconstructed lung airway images
Figure 2 shows how we reconstructed the longitudinal 
airway view and the view perpendicular to the airway axis 
Di
HR
UHR
UHR
with iDose4
1.0 mm 0.8 mm 0.3 mm
Di Di
Figure  1  Computed  tomography  images  of  phantoms  by  high-resolution  CT, 
ultrahigh-resolution CT, and ultrahigh-resolution CT with iDose4 (Philips healthcare) 
software. 
Abbreviations: Di, inner diameter; CT, computed tomography; Uhr, ultrahigh-
resolution.International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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Figure 2 Comparison of conventional view of ultrahigh-resolution CT, reconstructed longitudinal airway view, and perpendicular image of airway axis in two patients with 
chronic obstructive pulmonary disease. (A–C) Patient 1 and (D–F) patient 2. 
Abbreviation: CT, computed tomography.
compared with the conventional CT images. They show the 
relationships of one airway to other airways, lung vessels, 
and interlobular septa, many of which cannot be recognized 
on conventional CT images. Figure 3 shows definition of 
measurement points in a longitudinal image of the bron-
chial tree, and images exactly perpendicular to the airway 
axis at each point. An airway lumen of 0.8 mm was clearly 
identifiable.
Patient demographic data and types  
of emphysema correlated with 
longitudinal airway structure
Table 1 shows the patient demographic data. Overall, we 
studied a total of 700 airways in the 70 COPD patients and 
150 airways in the 15 normal controls. In the course of the 
study, we found that there were two types of emphysema 
in regard to middle or central zone airway luminal patency. 
Panel A in Figure 4 shows an airway that was patent from 
the central zone to just beneath the pleura. All airways in 
normal subjects and 90.3% of the airways in patients with 
COPD (632/700 airways) were patent at the peripheral zone 
(2 cm from the pleura).
Airway luminal obliteration was found in 9.7% of the air-
ways studied in patients with COPD (68/700 airways in 28/70 
COPD patients) at the middle or central zone airway (.2 cm 
apart from the pleura) as shown in panel C of Figure 4. 
Occlusion of the middle zone airways seemed to have a 
subsegmental distribution, the subpleural parenchyma was 
replaced by emphysema, and the lumen-obliterated airways 
could be traced into the emphysematous area. We labeled 
this type of emphysema as “airway lumen-obliterated 
emphysema”. More examples of airway lumen-obliterated 
emphysema are shown in Figure 5.
Lung structure and GOLD airflow 
limitation stages
Figure 6 summarizes the lung structure measured in the 
right B1–B10 bronchi for all cases grouped by GOLD stage. 
Intraclass correlation coefficients for every image parameter 
between two observers were over 0.6. The upper limit of 
%LAA in normal subjects was 6.5%, 7.6%, and 11.9% for 
the peripheral, middle, and central zone, respectively. Each 
zone showed significantly high %LAA even in spirometric 
stage I of COPD. Reductions in airways and vessels at the 
peripheral and middle zones were observed even in the early 
stages of COPD, and there was little difference between 
GOLD spirometric stage II and stage IV. In contrast, the 
Di of the peripheral, middle, and central zone airways was 
smaller in advanced spirometric stages.
Figure 7 shows the segmental %LAA (left panels) 
and percentage of airway lumen-obliterated emphysema 
according to GOLD spirometric stages (right panels). International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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A
C
B
D
Figure 3 Definition of measurement area in computed tomography images of airways in patients with chronic obstructive pulmonary disease. (A) longitudinal image of 
right B9a. Central zone (C) was defined as the point 2 cm from the entrance to the segmental bronchus; peripheral zone (P) was defined as the point 2 cm from the pleura; 
and middle zone (M) was defined as the point halfway between P and C. (B–D) Images exactly perpendicular to airway axis at each point (part B shows central zone; part C 
shows middle zone; and part D shows peripheral zone). The 3 cm circle indicates the selected airway. Within this circle, we measured the percentage of low attenuation 
area, number of bronchi, number of vessel structures, and the inner diameter of the center airway. 
Abbreviation: HU, Hounsfield units.
Table 1 Comparison of 70 male patients with COPD and 15 male controlsa
Variable Controls 
(n=15)
GOLD spirometric stages of COPD patients (n=70)
Stage I 
(n=20)
Stage II 
(n=21)
Stage III 
(n=19)
Stage IV 
(n=10)
P-valueb
age, years 65.7 (6.7) 70.8 (6.7) 70.6 (8.0) 72.4 (5.4) 70.2 (4.2) ns
never smoker 8 0 0 0 0
smoking index 12.1 (16.1) 74.7 (38.1) 74.9 (37.6) 80.4 (26.8) 80.3 (34.3) ns
Body mass index 23.3 (2.7) 21.2 (3.8) 21.5 (3.7) 20.3 (2.7) 18.5 (3.8) ns
FVC, %c 96.5 (11.5) 101.5 (19.2) 84.6 (13.5) 74.7 (13.5) 59.5 (13.1) ns
FeV1, %c 114.1 (15.7) 103.2 (14.8)d 60.8 (7.2)e 40.2 (5.2)e 26.3 (3.2)e ,0.0001
MeF75, %c 108.9 (19.9) 54.2 (19.5)e 17.9 (8.0)e 7.9 (3.8)e 4.7 (1.9)e ,0.0001
MeF50, %c 86.1 (18.6) 30.8 (10.3)e 11.9 (5.2)e 6.3 (2.2)e 4.2 (2.0)e ,0.0001
MeF25, %c 76.7 (21.2) 32.3 (14.5)e 17.4 (8.4)e 12.3 (5.1)e 7.7 (3.5)e ,0.0001
Notes: aValues are shown as the mean (standard deviation) unless indicated otherwise; bsignificance of difference among all groups was analyzed by analysis of variance; 
cpredicted; dP,0.05 versus controls by the Tukey–Kramer multiple comparison test; eP,0.001 versus controls by the Tukey–Kramer multiple comparison test. 
Abbreviations: COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FeV1, forced expiratory volume in one second; gOlD, global initiative for 
chronic Obstructive Lung Disease; MEF75, maximum expiratory flow at 75% FVC; MEF50, maximum expiratory flow at 50% FVC; MEF25, maximum expiratory flow at 25% 
FVC.
Segmental emphysematous areas were high in segment 1 in 
all stages, but the %LAA in the lower lobe segments was 
also high in advanced spirometric stages. Airway lumen-
obliterated emphysema was predominantly observed in the 
segments of lower lobe in the advanced spirometric stages.
relationship between lung structure  
and pulmonary function
All image parameters except the numbers of central zone 
airways were significantly associated with every spirometric 
parameter (Table 2). Stepwise multiple regression analysis International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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Figure 4 Computed tomography images of severe emphysema and airway lumen-
obliterated  emphysema.  (A)  reconstructed  image  of  longitudinal  airway  view 
of severe emphysema with little parenchyma around septum or vessels (arrows 
indicate the point where image B was reconstructed within 2 cm from pleura). 
(B) reconstructed image of view exactly perpendicular image to airway axis at red 
line in panel A (arrows indicate the airway used for image reconstruction). even in 
peripheral airway within 2 cm from the pleura airway lumens could be observed. 
green line indicates the size of the airway. (C) reconstructed image of longitudinal 
airway view of airway lumen-obliterated emphysema. The airway lumen is obliterated 
at the proximal levels of the bronchi (.2 cm apart from the surface of the lung), and 
subsegmental areas lacking parenchyma were observed. The obliterated bronchus 
could be traced into the air-trapped emphysematous area (arrows indicate the 
point where image D was reconstructed). (D) reconstructed image of view exactly 
perpendicular to the long axis of the bronchus at the red line in panel C. red circle 
indicates the airway which was used for image reconstruction.
Case 1
A
B
CE
DF
Case 2C ase 3
Figure 5 Three cases of airway lumen-obliterated emphysema. (A, C and E) reconstructed images of longitudinal airway view of airway lumen-obliterated emphysema. red 
lines indicate the points where perpendicular images were reconstructed. (B, D and F) reconstructed images of view exactly perpendicular image to airway axis at red lines 
in panel A, C, and E, respectively.
of CT image parameters versus spirometric parameters 
showed that spirometric parameters were best predicted by 
the combination of middle zone emphysema, the number 
of airways in the peripheral zone, and the Di, including 
total zone area (mean of three levels) or central zone area 
(Table 3). However, correlation coefficients (r) were dif-
ferent among the spirometric parameters. The fast exhaled 
breath compartment, as expressed by FEV1 was largely 
predicted by total Di, whereas slow exhaled breath com-
partments, such as MEF50, was more predicted by middle 
zone emphysema and numbers of peripheral zone airways, 
and MEF25 was mostly predicted by numbers of peripheral 
zone airways.
Discussion
In this study, we showed that airway numbers, airway diam-
eter, and extent of emphysematous change as identified 
and measured on CT are all associated with spirometric 
  parameters. Mean airway diameter of the three levels of 
bronchi, an emphysematous area at the middle zone, and 
number of peripheral airways were independent predictors 
of FEV1. Since FEV1 was not a sensitive marker for emphy-
sema in this study, significant emphysema predominant in 
the upper lobe could be observed, even in early spirometric 
stages. In addition, the longitudinal airway view revealed a 
distinctive type of emphysema characterized by middle or 
central zone airway lumen obliteration and destruction of International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 6 Percentage of low attenuation area, number of airways, number of vessels and airway inner diameter in patients with chronic obstructive pulmonary disease 
grouped by gOlD stage and compared with controls. Bar graphs show summaries of lung structures in the 3 cm circle around the selected bronchus measured in right B1 
to B10 bronchi. Means and standard error bars are shown. The peripheral zone was defined as the point 2 cm from the pleura; the central zone was defined as the point 
2 cm from the entrance to the segmental bronchus; the middle zone was designated as the point half-way between the peripheral and central zone. analysis of variance was 
used to determine the overall difference among groups, and the Tukey–Kramer multiple comparison test was used to compare groups. Significances between the controls 
(normal) and each GOLD airflow limitation stage (I–IV) are shown. Asterisks indicate *P,0.05, **P,0.01, and ***P,0.001 compared with controls. 
Abbreviations: gOlD, global initiative for chronic Obstructive lung Disease; %laa, percentage of low attenuation area,
subsegmental parenchyma; this was found predominantly 
in the late spirometric stages.
Until recently, it has not been possible to observe an 
airway less than 1 mm in diameter with high-resolution CT 
directly. The current study used three technical modifications 
or enhancements to observe such airways directly in patients 
with COPD. The first was the use of a thin detector filter 
(0.39 × 0.39 mm matrix) to increase resolution (UHR mode). 
However, use of a thin detector filter reduces the signal level 
and enhances noise. Removal of this CT noise and motion 
noise by the heart was obtained by the second modification, 
which involved use of hybrid interactive reconstruction 
software (iDose4). The third and most important technical 
enhancement was the reconstruction of longitudinal airway 
images of select airways and perpendicular short-axis images 
at any airway level. By cutting the airway image exactly 
perpendicular to its long axis, we could observe and mea-
sure thin-walled airways less than 1 mm in diameter and the 
interlobular septa, structures that are not usually visible with 
conventional high-resolution CT.18 In patients with emphy-
sema, most of the peripheral zone airways, ie, those 2 cm 
from the pleura, were patent, and subpleural lung parenchyma 
was partially preserved between the airways and the pleura. 
Reconstructed longitudinal images of the airways revealed 
that interstitial tissue around the airways was preserved to 
varying extents and connected with lung vessels and airways 
in emphysematous lung tissue.
Airway resistance is well known to exist largely in the 
small airways of patients with COPD.4,19 Our results are not 
necessarily discordant with this, because airway resistance 
and airflow limitation at spirometry would reflect different 
lung structures. In addition, our data showed that the middle 
zone airways were not small airways in controls, but mean Di 
at the middle zone was less than 2 mm in advanced stages of 
COPD. Therefore, a considerable portion of the middle zone 
airways were small airways in this study.International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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Figure 7 segmental low attenuation area by gOlD stage and percentages of airway lumen-obliterated emphysema by gOlD stage. (left panels) The segmental low 
attenuation area (laa) is a mean of the laa in the peripheral, middle, and central zones of each bronchus. analysis of variance with the Tukey–Kramer multiple comparison 
test was used to compare groups. Asterisks indicate *P,0.05; **P,0.01; and ***P,0.001 compared with controls. (right panels) The percentage of airway lumen-obliterated 
emphysema in each segment (part A) and according to GOLD airflow limitation stages (part B) were significantly different with the Kruskal–Wallis test. 
Abbreviations: gOlD, global initiative for chronic Obstructive lung Disease; n, normal controls; I, stage I; II, stage II; III, stage III; and IV, stage IV.
Table 2 relationships between airway dimensions and pulmonary function in COPD
Variable FEV1, %a, rb P-value MEF75, %a, rb P-value MEF50, %a, rb P-value MEF25, %a, rb P-value
%laa
  Peripheral zone -0.68 ,0.0001 -0.706 ,0.0001 -0.681 ,0.0001 -0.593 ,0.0001
  Middle zone -0.601 ,0.0001 -0.675 ,0.0001 -0.673 ,0.0001 -0.581 ,0.0001
  Central zone -0.494 ,0.0001 -0.54 ,0.0001 -0.533 ,0.0001 -0.454 ,0.0001
  Total zone -0.621 ,0.0001 -0.673 ,0.0001 -0.661 ,0.0001 -0.57 ,0.0001
airways, n
  Peripheral zone 0.618 ,0.0001 0.687 ,0.0001 0.74 ,0.0001 0.722 ,0.0001
  Middle zone 0.56 ,0.0001 0.663 ,0.0001 0.708 ,0.0001 0.68 ,0.0001
  Central zone 0.074 ns 0.07 ns 0.054 ns 0.091 ns
  Total zone 0.599 ,0.0001 0.682 ,0.0001 0.724 ,0.0001 0.713 ,0.0001
Vessels, no
  Peripheral zone 0.47 ,0.0001 0.583 ,0.0001 0.625 ,0.0001 0.599 ,0.0001
  Middle zone 0.524 ,0.0001 0.613 ,0.0001 0.63 ,0.0001 0.571 ,0.0001
  Central zone 0.466 ,0.0001 0.537 ,0.0001 0.547 ,0.0001 0.499 ,0.0001
  Total zone 0.524 ,0.0001 0.624 ,0.0001 0.649 ,0.0001 0.602 ,0.0001
airway inner diameter, mm
  Peripheral zone 0.614 ,0.0001 0.612 ,0.0001 0.569 ,0.0001 0.542 ,0.0001
  Middle zone 0.667 ,0.0001 0.649 ,0.0001 0.614 ,0.0001 0.561 ,0.0001
  Central zone 0.466 ,0.0001 0.659 ,0.0001 0.606 ,0.0001 0.537 ,0.0001
  Total zone 0.723 ,0.0001 0.71 ,0.0001 0.563 ,0.0001 0.603 ,0.0001
Notes: aPredicted; bPearson correlation coefficients (r) are expressed for spirometric parameters and their relationship to the area of emphysema (%laa), number of 
airways, number of vessels, and airway inner diameter of 3 mm circles. around the airway at the peripheral zone (2 cm from the pleura), the central zone (2 cm from the 
entrance to the segmental bronchus), and the middle zone (half-way point between the central and peripheral zones). The averages of image parameters of right B1 to right 
B10 are used. 
Abbreviations: FeV1, forced expiratory volume in one second; %LAA, percentage of low attenuation area; MEF25, maximum expiratory flow at 25% forced vital capacity; 
MEF50, maximum expiratory flow at 50% forced vital capacity; MEF75, maximum expiratory flow at 75% forced vital capacity; NS, not statistically significant.International Journal of COPD 2013:8 submit your manuscript | www.dovepress.com
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Table 3 Standard regression coefficients and correlation coefficient (r values) of stepwise multiple regression analysis for PFTs
SRC SRC SRC r P-value
FeV1, %a Pna 0.183 Mlaa -0.328 TDi 0.491 0.816 ,0.0001
MeF75, %a Pna 0.274 Mlaa -0.396 TDi 0.399 0.859 ,0.0001
MeF50, %a Pna 0.435 Mlaa -0.384 CDi 0.268 0.862 ,0.0001
MeF25, %a Pna 0.462 Mlaa -0.282 TDi 0.226 0.796 ,0.0001
Note: aPredicted. 
Abbreviations: PFTs, pulmonary function tests; SRC, standard regression coefficient; MLAA, low attenuation area at middle zone (%); PNa, airway numbers at peripheral 
zone; TDi, total zone airway diameter (mm); CDi, airway diameter at central zone (mm); MEF75, maximum expiratory flow at 75% forced vital capacity; MEF50, maximum 
expiratory flow at 50% forced vital capacity; MEF25, maximum expiratory flow at 25% forced vital capacity.
Hasegawa et al20 previously showed that the luminal area 
in the peripheral airways correlated more with FEV1 than the 
luminal area in the central airways. However, Hasegawa et al 
used a lower limit of peripheral airway diameter of 2 mm, 
which corresponds approximately to the middle zone in this 
study. In accordance with their data, our findings show that Di 
in the middle zone and in the peripheral zone correlate more 
with FEV1 than Di in the central zone (Table 2). Previous 
studies also compared dimensions of the airways by extent of 
airway generation.17,20,21 Since the number of airway genera-
tions differs depending on the length of the pathway followed,22 
we analyzed peripheral, middle, and central zone airways as 
determined by distance from the pleura and entrance to the seg-
mental bronchus, rather than by specific airway generation.
Nakano et al23 reported that the airway wall of a single 
apical bronchus of the right upper lobe and total lung LAA 
predicted percent FEV1. Diaz et al24 showed the relationship 
between FEV1 and a reduction in the number of airways in the 
right B1. In our study, we found that the fast exhaled breath 
compartment, as expressed by FEV1, correlated best with air-
way diameter, whereas the slow exhaled breath compartment, 
such as MEF50 and MEF25, correlated best with the extent of 
middle zone emphysema and number of peripheral airways. 
Because elastic recoil and speed of airflow are greatest near 
total lung capacity, airflow may become progressively more 
dependent on extent of emphysema and airway number as lung 
volume decreases. Recent studies have shown that the extent 
of emphysema in COPD is associated with COPD prognosis, 
the annual decline in FEV1, and systemic complications.25–27 
However, our findings suggest that FEV1 may not be a sensitive 
marker for emphysema as detected on CT scan.
Our results suggest that there are two types of airway loss 
in COPD. One type is the actual disappearance of airways. 
Previously, McDonough et al8 showed that the number of 
airways measuring 2.0–2.5 mm in diameter was reduced 
in patients with COPD. In addition to the disappearance of 
airways, we identified airways with complete luminal oblit-
eration associated with surrounding emphysema (ie, airway 
lumen-obliterated emphysema). We identified this type of 
emphysema on longitudinal view of the airways. As seen on 
CT scans, in this type of emphysema, the middle or central 
zone airway has a gradually tapered inner lumen that eventu-
ally ends in a blind pouch. A luminal-obliterated airway may 
still be apparent as a line in the air-trapped emphysematous 
area, and is accompanied by destruction of the surrounding 
subsegmental parenchyma (ie, emphysema). Although not 
supported by direct pathologic data, the images imply that 
permanent proximal airway obliteration caused distal air trap-
ping and destruction of the segmental parenchyma. Simple 
loss of airway patency could be observed due to mucus in the 
airway in COPD or bronchoconstriction in asthma. However, 
these situations can be reversible, differ on CT imaging, 
and are not accompanied by parenchymal destruction of the 
affected airway segments (images not shown). Our prelimi-
nary observation in only a few cases suggests that some of the 
airway lumen-obliterated emphysema had developed by one 
or 2 years after bronchopneumonia in patients with COPD 
(unpublished data). However, the mechanisms and clinical 
significance of this type of emphysema should be studied 
further in the future.
There are several limitations to this study that should be 
noted. Professional guidelines from the American Thoracic 
Society and European Respiratory Society state that quantify-
ing the number of lung structures in two-dimensional images 
should accurately represent three-dimensional structures 
when special sampling and analytical strategies are used.28 
We set the two-dimensional area perpendicular to the air-
way axis for sampling. This might not represent all three-
dimensional structures; however, it is an objective scheme 
that avoids bias at all three levels of the airway. Another 
limitation is that all the patients entered into this study were 
men. Finally, the pathology of airway lumen-obliterated 
emphysema is not clear; well preserved specimens are dif-
ficult to come by, and such a change would be difficult to 
examine pathologically because there is so little parenchyma 
around the remnant airways.International Journal of COPD
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In conclusion, percent FEV1, a parameter of rapid expi-
ration, is most associated with total zone airway diameter, 
and spirometric parameters during slow expiration are more 
associated with middle zone emphysema and the number of 
peripheral zone airways in patients with COPD. We showed 
that percent FEV1 is not a sensitive marker for severity of 
emphysema. Airway lumen-obliterated emphysema was 
observed predominantly in the advanced spirometric stages of 
COPD, and their pathologic nature and clinical significance 
need to be studied in the future.
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